SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-16-014425
Filing Date
2016-11-07
Accepted
2016-11-07 17:25:02
Documents
55
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2016 a11216110q.htm 10-Q 922388
2 EXHIBIT 10.4 ex10_4.htm EX-10.4 18960
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 14001
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 14126
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 5542
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 5212
13 chart1.jpg GRAPHIC 72534
  Complete submission text file 0001214659-16-014425.txt   3893620

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT anth-20160930.xml EX-101.INS 634820
8 XBRL TAXONOMY EXTENSION SCHEMA anth-20160930.xsd EX-101.SCH 32253
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anth-20160930_cal.xml EX-101.CAL 38305
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anth-20160930_def.xml EX-101.DEF 143800
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE anth-20160930_lab.xml EX-101.LAB 261649
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anth-20160930_pre.xml EX-101.PRE 222612
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34637 | Film No.: 161979272
SIC: 2834 Pharmaceutical Preparations